|
1
|
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
|
N Engl J Med
|
2011
|
10.79
|
|
2
|
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
|
N Engl J Med
|
2012
|
6.64
|
|
3
|
Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial.
|
Trop Med Int Health
|
2009
|
4.54
|
|
4
|
Research capacity. Enabling the genomic revolution in Africa.
|
Science
|
2014
|
3.05
|
|
5
|
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
|
Lancet
|
2007
|
2.99
|
|
6
|
Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
|
N Engl J Med
|
2016
|
2.50
|
|
7
|
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
|
PLoS One
|
2009
|
2.43
|
|
8
|
Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria-attributable fever during low and high transmission season in Burkina Faso.
|
Malar J
|
2010
|
1.88
|
|
9
|
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing.
|
Malar J
|
2008
|
1.85
|
|
10
|
An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso.
|
Malar J
|
2012
|
1.39
|
|
11
|
Pyronaridine-artesunate versus mefloquine plus artesunate for malaria.
|
N Engl J Med
|
2012
|
1.36
|
|
12
|
Challenges of non-commercial multicentre North-South collaborative clinical trials.
|
Trop Med Int Health
|
2012
|
1.09
|
|
13
|
Evaluation of antigen detection tests, microscopy, and polymerase chain reaction for diagnosis of malaria in peripheral blood in asymptomatic pregnant women in Nanoro, Burkina Faso.
|
Am J Trop Med Hyg
|
2012
|
1.07
|
|
14
|
Performance of OptiMAL-IT compared to microscopy, for malaria detection in Burkina Faso.
|
Trop Med Int Health
|
2009
|
1.06
|
|
15
|
Profile: Nanoro Health and Demographic Surveillance System.
|
Int J Epidemiol
|
2012
|
1.03
|
|
16
|
Antigen persistence of rapid diagnostic tests in pregnant women in Nanoro, Burkina Faso, and the implications for the diagnosis of malaria in pregnancy.
|
Trop Med Int Health
|
2012
|
1.02
|
|
17
|
Strict adherence to malaria rapid test results might lead to a neglect of other dangerous diseases: a cost benefit analysis from Burkina Faso.
|
Malar J
|
2011
|
1.00
|
|
18
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
19
|
Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso.
|
Malar J
|
2014
|
0.98
|
|
20
|
Could the decision of trial participation precede the informed consent process? Evidence from Burkina Faso.
|
PLoS One
|
2013
|
0.97
|
|
21
|
Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
|
Malar J
|
2014
|
0.95
|
|
22
|
Paracheck® rapid diagnostic test for detecting malaria infection in under five children: a population-based survey in Burkina Faso.
|
Malar J
|
2014
|
0.91
|
|
23
|
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
|
Malar J
|
2010
|
0.90
|
|
24
|
Artemisinin resistance in rodent malaria--mutation in the AP2 adaptor μ-chain suggests involvement of endocytosis and membrane protein trafficking.
|
Malar J
|
2013
|
0.90
|
|
25
|
Antiplasmodial compounds from Cochlospermum tinctorium.
|
J Nat Prod
|
2002
|
0.88
|
|
26
|
Malaria mortality estimates: need for agreeable approach.
|
Trop Med Int Health
|
2012
|
0.88
|
|
27
|
Clinical signs and symptoms cannot reliably predict Plasmodium falciparum malaria infection in pregnant women living in an area of high seasonal transmission.
|
Malar J
|
2013
|
0.85
|
|
28
|
The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso.
|
Malar J
|
2014
|
0.83
|
|
29
|
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso.
|
PLoS One
|
2013
|
0.82
|
|
30
|
Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial.
|
Trials
|
2014
|
0.81
|
|
31
|
Participation in medical research as a resource-seeking strategy in socio-economically vulnerable communities: call for research and action.
|
Trop Med Int Health
|
2014
|
0.79
|
|
32
|
Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.
|
Trials
|
2013
|
0.77
|
|
33
|
Correction: Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach.
|
PLoS Negl Trop Dis
|
2017
|
0.75
|